开始
yussray

Drug completed trial ORION 10

做多
yussray  
NASDAQ:MDCO   None
Trend Analysis catalyst
7
1
trendanalysis catalyst
Successful Completion pf phase 3 trial marks another discovery for the company and ready to bring the cardiovascular drug to another level.

Todays price @ 50.55
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。